Insider · CIK 0001868501
Deepak Srivastava
Files at TNYA (Tenaya Therapeutics, Inc.). First filing -, latest -.
In brief
Deepak Srivastava files SEC Form 4 as director at TNYA (Tenaya Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Deepak Srivastava has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | May 29, 2026 |
| May 29, 2025 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +107,400 | $0.00 | $0 | 107,400 | May 30, 2025 |
| Oct 18, 2024 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +34,000 | $0.00 | $0 | 34,000 | Oct 21, 2024 |
Questions about Deepak Srivastava
Answered from the filings on this page, as of the latest one.
Is Deepak Srivastava buying or selling?
Deepak Srivastava has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Deepak Srivastava's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Deepak Srivastava has 0.
Where does Deepak Srivastava file Form 4?
Deepak Srivastava has filed Form 4 at TNYA (Tenaya Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.